Product Information
OXAZEPAM 30 MG CAPSULE is a generic product labeled by Leading Pharma, LLC, priced at $1.1370 per EA under NDC 69315091301. Its NADAC has been published 44 times since Aug 27, 2025.
Strength
30 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315091301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA218261On Market Since
7/9/2025
Pharmacological Classes
Price Statistics
The NADAC for OXAZEPAM 30 MG CAPSULE has been published 44 times since Aug 27, 2025, and over the history we have for it it has declined 16.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1370 per EA |
|---|---|
| All-time high | $1.3640 (Sep 10, 2025) |
| All-time low | $1.1218 (May 20, 2026) |
| 52-week high | $1.3640 |
| 52-week low | $1.1218 |
| Median price | $1.2466 |
| Average price | $1.2371 |
| Largest weekly change | -5.1% (Mar 18, 2026) |
| Weeks tracked | 44 |
| Tracking since | Aug 27, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the OXAZEPAM market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OXAZEPAM 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OXAZEPAM 30 MG CAPSULE, manufactured by Leading Pharma, LLC, is $1.1370 per EA (NDC 69315091301), effective Jun 24, 2026.
How has the price of OXAZEPAM 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OXAZEPAM 30 MG CAPSULE has declined 16.6%. It has been tracked across 44 weekly CMS publications since Aug 27, 2025.
What are the highest and lowest recorded NADAC prices for OXAZEPAM 30 MG CAPSULE?
Since Aug 27, 2025, the NADAC for OXAZEPAM 30 MG CAPSULE has ranged from a low of $1.1218 (May 20, 2026) to a high of $1.3640 (Sep 10, 2025), with a median of $1.2466 per EA.
Are there cheaper alternatives to OXAZEPAM 30 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OXAZEPAM 30 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures OXAZEPAM 30 MG CAPSULE?
OXAZEPAM 30 MG CAPSULE (NDC 69315091301) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification